| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 07/01/2004 | US20040127523 Methods of treating cancer with HDAC inhibitors |
| 07/01/2004 | US20040127522 histone deacetylase inhibitors administered in a safe, daily dosing regimen to have high oral bioavailability |
| 07/01/2004 | US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel |
| 06/30/2004 | EP0832875B1 Highly water-soluble metalloproteinase inhibitor |
| 06/29/2004 | US6756406 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 06/29/2004 | CA2151817C Process for the preparation of hydroxylamine ethers and their salts and intermediates for this purpose |
| 06/24/2004 | WO2004052919A2 Peptide deformylase inhibitors |
| 06/24/2004 | US20040122101 Polymorphs of suberoylanilide hydroxamic acid |
| 06/24/2004 | US20040122057 Novel mandelic acid derivatives |
| 06/24/2004 | US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/23/2004 | CN1507441A Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
| 06/17/2004 | WO2004050620A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/16/2004 | EP1427701A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/10/2004 | WO2004048335A2 Mandelic acid derivatives |
| 06/10/2004 | WO2004033413A3 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | CA2505542A1 Mandelic acid derivatives |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/03/2004 | WO2004046104A2 Treatment of lung cells with histone deacetylase inhibitors |
| 06/03/2004 | WO2004046096A2 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/03/2004 | US20040106795 Peptide deformylase inhibitors |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | CA2506504A1 Treatment of lung cells with histone deacetylase inhibitors |
| 06/02/2004 | CN1500769A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 06/02/2004 | CN1151836C Compounds and compositions for delivering active agents |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102491 Antimicrobial agents |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/25/2004 | US6739454 Reaction of the methyl or ethyl ester of a fatty acid having 6 to 22 carbon atoms with a hydroxylamine salt and an alkali metal hydroxide in the presence of water, either a hydrocarbon oil or a fatty oil |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/19/2004 | EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases |
| 05/19/2004 | CN1496999A Solid phase synthesing method of aldehyde, ketonic, oxime amine and isohydroximic acid compound |
| 05/13/2004 | WO2003086316A3 Degradable crosslinkers, and degradable crosslinked hydrogels comprising them |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092553 Excitatory amino acid receptor modulators |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/12/2004 | EP1052984B1 Antibacterial agents |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
| 05/06/2004 | US20040087631 Anticancer agents; using histone deacetylase; bioavailability |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040086460 Chelate metal ions that can be detected either by their paramagnetic or radioactive properties; diagnostic and therapeutic agents |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 04/29/2004 | WO2004035533A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 04/29/2004 | CA2502527A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 04/28/2004 | EP0558648B1 Improved matrix metalloprotease inhibitors |
| 04/22/2004 | WO2004033413A2 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077727 Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23 |
| 04/22/2004 | US20040077691 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 04/22/2004 | CA2498940A1 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 04/21/2004 | EP1408946A2 Histone deacetylase inhibitors |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/20/2004 | USRE38506 Potent inducers of terminal differentiation and methods of use thereof |
| 04/15/2004 | US20040072735 Administering suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylase (HDAC) to a patient for cancer cell growth arrest and/or apoptosis of neoplastic cells |
| 04/08/2004 | WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/07/2004 | EP0910561B1 Inhibitors of oleamide hydrolase |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/01/2004 | WO2004026824A1 Process for preparing intermediates |
| 04/01/2004 | CA2499426A1 Process for preparing n-hydroxylamine compounds |
| 03/31/2004 | EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/30/2004 | US6713646 Degradable crosslinkers, and degradable crosslinked hydrogels comprising them |
| 03/30/2004 | US6713510 Amide and ester derivatives |
| 03/25/2004 | WO2004024677A1 N-hydroxyformamidine derivative |
| 03/25/2004 | US20040059156 Preparation of fatty hydroxamate |
| 03/24/2004 | EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 03/24/2004 | EP1399416A2 Peptide deformylase inhibitors |
| 03/23/2004 | US6710208 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and α,β-unsaturated carboxylic acid and aldehyde compounds |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040053932 Peptide deformylase inhibtors |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/10/2004 | EP1081132B1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1480455A 'Sqiqu site' ramification and its preparing method as well as its activity of anti asthma |
| 03/10/2004 | CN1141293C Process for synthesizing anidoxime |
| 03/10/2004 | CN1141292C Cytostatic agents |
| 03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
| 02/26/2004 | US20040039025 Substituted hydrazine derivatives |